The interaction of amyloid β-peptide (Aβ) with the iron-storage protein ferritin was studied in vitro. We have shown that Aβ during fibril formation process is able to reduce Fe(III) from the ferritin core (ferrihydrite) to Fe(II). The Aβ-mediated Fe(III) reduction yielded a two-times-higher concentration of free Fe(II) than the spontaneous formation of Fe(II) by the ferritin itself. We suggest that Aβ can also act as a ferritin-specific metallochaperone-like molecule capturing Fe(III) from the ferritin ferrihydrite core. Our observation may partially explain the formation of Fe(II)-containing minerals in human brains suffering by neurodegenerative diseases.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Jarrett, J.T., Berger, E.P., Lansbury, P.T.: The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease. Biochemistry 32, 4693–4697 (1993)
El-Agnaf, O.M.A., Mahil, D.S., Patel, B.P., Austen, B.M.: Oligomerization and toxicity of β-amyloid-42 implicated in Alzheimer’s disease. Biochem. Biophys. Res. Commun. 273, 1003–1007 (2000)
Selkoe, D.J.: Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81, 741–766 (2001)
Hilbich, C., Kisterswoike, B., Reed, J., Masters, C.L., Beyreuther, K.: Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer’s disease βA4 peptides. J. Mol. Biol. 228, 460–473 (1992)
Soto, C., Castaño, E.M., Kumar, R.A., Beavis, R.C., Frangione, B.: Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure. Neurosci. Lett. 200, 105–108 (1995)
Tjernberg, L.O., Naslund, J., Lindqvist, F., Johansson, J., Karlstrom, A.R., Thyberg, J., Terenius, L., Nordstedt, C.: Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271, 8545–8548 (1996)
Everett, J., Cespedes, E., Shelford, L.R., Exley, C., Collingwood, J.F., Dobson, J., van der Laan, G., Jenkins, C.A., Arenholz, E., Telling, N.D.: Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer’s disease peptide β-amyloid. Inorg. Chem. 53, 2803–2809 (2014)
Scarpini, E., Scheltens, P., Feldman, H.: Treatment of Alzheimer’s disease: current status and new perspectives. Lancet Neurol. 2, 539–547 (2003)
Pankhurst, Q., Hautot, D., Khan, N., Dobson, J.: Increased levels of magnetic iron compounds in Alzheimer's disease. J. Alzheimers Dis. 13, 49–52 (2008)
Brillas, E., Sirés, I., Oturan, M.A.: Electro-Fenton process and related electrochemical technologies based on Fenton’s reaction chemistry. Chem. Rev. 109, 6570–6631 (2009)
Crichton, R.R., Dexter, D.T., Ward, R.J.: Brain iron metabolism and its perturbation in neurological diseases. J. Neural Transm. 118, 301–314 (2011)
Zecca, L., Youdim, M.B.H., Riederer, P., Connor, J.R., Crichton, R.R.: Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863–873 (2004)
Everett, J., Cespedes, E., Shelford, L.R., Exley, C., Collingwood, J.F., Dobson, J., van der Laan, G., Jenkins, C.A., Arenholz, E., Telling, N.D.: Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer’s disease peptide β-amyloid (1-42). J. Royal Soc. Interface 11, 20140165 (2014)
Riemer, J., Hoepken, H.H., Czerwinska, H., Robinson, S.R., Dringen, R.: Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal. Biochem. 331, 370–375 (2004)
Khan, A., Dobson, J.P., Exley, C.: Redox cycling of iron by Aβ42. Free Radic. Biol. Med. 40, 557–569 (2006)
Jutz, G., van Rijn, P., Santos Miranda, B., Böker, A.: Ferritin: a versatile building block for bionanotechnology. Chem. Rev. 115, 1653–1701 (2015)
Watt, R.K., Hilton, R.J., Graff, D.M.: Oxido-reduction is not the only mechanism allowing ions to traverse the ferritin protein shell. Biochim. Biophys. Acta Gen. Subj. 1800, 745–759 (2010)
Carmona, F., Palacios, O., Galvez, N., Cuesta, R., Atrian, S., Capdevila, M., Dominguez-Vera, J.M.: Ferritin iron uptake and release in the presence of metals and metalloproteins: chemical implications in the brain. Coor. Chem. Rev. 257, 2752–2764 (2013)
Philpott, C.C., Ryu, M.-S.: Special delivery: distributing iron in the cytosol of mammalian cells. Front. Pharmacol. 5, 173 (2014)
Tahirbegi, I.B., Pardo, W.A., Alvira, M., Mir, M., Samitier, J.: Amyloid Aβ 42, a promoter of magnetite nanoparticle formation in Alzheimer’s disease. Nanotechnology 27, 465102 (2016)
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Elst, L.V., Muller, R.N.: Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064–2110 (2008)
Khurana, R., Coleman, C., Ionescu-Zanetti, C., Carter, S.A., Krishna, V., Grover, R.K., Roy, R., Singh, S.: Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 151, 229–238 (2005)
Vassar, P.S., Culling, C.F.: Fluorescent stains, with special reference to amyloid and connective tissues. Arch. Pathol. 68, 487–498 (1959)
LeVine III, H.: Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2, 404–410 (1993)
Huang, X., Atwood, C.S., Hartshorn, M.A., Multhaup, G., Goldstein, L.E., Scarpa, R.C., Cuajungco, M.P., Gray, D.N., Lim, J., Moir, R.D., Tanzi, R.E., Bush, A.I.: The Aβ peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609–7616 (1999)
This work was supported by VEGA Grant Agency (project No. 2/0062/16, 2/0016/17, 0045, 2/0062/14, 2/0009/17), the Slovak Research and Development Agency (contract No. APVV-015-0453) and the Ministry of Education Agency for European Structural Funds (projects No. 26220120021, 2622012033, 26220220061, and 26220220186).
About this article
Cite this article
Balejcikova, L., Siposova, K., Kopcansky, P. et al. Fe(II) formation after interaction of the amyloid β-peptide with iron-storage protein ferritin. J Biol Phys 44, 237–243 (2018). https://doi.org/10.1007/s10867-018-9498-3
- Iron reduction
- Alzheimer’s disease